The nine patients who received MMF/tacrolimus only had an overall mortality of 11.1% compared to the patients who ever received AZA/cyclosporine who had a mortality of 22.5%, although this difference did not reach statistical significance ( p = 0.45).
← all excerpts
Impact of pre-transplant time on dialysis on survival in patients with lupus nephritis.
1
0.4500
0.4500